PPARA and hyperlipidemia: Activation of LXR by TO901317 and PPARα by fenofibrate in combination improves glucose tolerance, alleviates insulin resistance, and blocks TO901317-induced hyperlipidaemia, but aggravates hepatic steatosis in high fat diet-induced obese mice [146].